Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 39.70
+1.40 (3.66%)
Nov 2, 2026, 4:25 PM CET
Gentian Diagnostics ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 91.38 | 105.93 | 84.74 | 87.64 | 81.6 | 114.94 |
Cash & Short-Term Investments | 91.38 | 105.93 | 84.74 | 87.64 | 81.6 | 114.94 |
Cash Growth | 5.48% | 25.01% | -3.31% | 7.41% | -29.00% | -27.25% |
Accounts Receivable | 47.43 | 13.79 | 23.29 | 11.57 | 10.06 | 6.51 |
Other Receivables | - | 10.48 | 7.98 | 5.41 | 9.13 | 16.07 |
Receivables | 47.43 | 24.27 | 31.28 | 16.98 | 19.19 | 22.58 |
Inventory | 52.48 | 54.14 | 45.94 | 37.12 | 38.54 | 29.78 |
Other Current Assets | - | - | -0 | - | 0 | - |
Total Current Assets | 191.3 | 184.34 | 161.96 | 141.73 | 139.33 | 167.3 |
Property, Plant & Equipment | 23.33 | 25.55 | 14.02 | 18.05 | 21.64 | 19.49 |
Other Intangible Assets | 4.01 | 35.83 | 28.46 | 21.16 | 26.82 | 25.01 |
Long-Term Deferred Tax Assets | 15.72 | 12.82 | 25.23 | - | - | - |
Other Long-Term Assets | - | - | - | 0.1 | 0 | 0 |
Total Assets | 234.36 | 258.54 | 229.66 | 181.04 | 187.79 | 211.79 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 27.58 | 2.45 | 6.55 | 3.71 | 4.44 | 4.98 |
Accrued Expenses | - | 6.42 | 6.19 | 4.57 | 4.97 | 3.6 |
Current Portion of Leases | - | 3.55 | 4.53 | 4.04 | 3.7 | 4.11 |
Other Current Liabilities | - | 21.72 | 12.84 | 13 | 8.89 | 9.87 |
Total Current Liabilities | 27.58 | 34.14 | 30.11 | 25.32 | 22 | 22.55 |
Long-Term Leases | 15.92 | 19.44 | 5.51 | 9.01 | 11.62 | 14.47 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.07 | - | - |
Other Long-Term Liabilities | 0 | - | -0 | - | - | - |
Total Liabilities | 43.5 | 53.58 | 35.61 | 34.4 | 33.62 | 37.02 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.55 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 |
Additional Paid-In Capital | 321.19 | 318.03 | 314.72 | 312.14 | 309.1 | 305.75 |
Retained Earnings | -131.88 | -114.62 | -122.21 | -167.05 | -156.48 | -132.53 |
Comprehensive Income & Other | - | - | 0 | 0 | 0 | 0 |
Shareholders' Equity | 190.86 | 204.96 | 194.05 | 146.64 | 154.17 | 174.77 |
Total Liabilities & Equity | 234.36 | 258.54 | 229.66 | 181.04 | 187.79 | 211.79 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 15.92 | 22.99 | 10.04 | 13.05 | 15.32 | 18.58 |
Net Cash (Debt) | 75.46 | 82.94 | 74.7 | 74.59 | 66.28 | 96.35 |
Net Cash Growth | -10.93% | 11.03% | 0.14% | 12.55% | -31.21% | -29.00% |
Net Cash Per Share | 4.89 | 5.35 | 4.74 | 4.84 | 4.30 | 6.25 |
Filing Date Shares Outstanding | 15.46 | 15.42 | 15.42 | 15.42 | 15.42 | 15.42 |
Total Common Shares Outstanding | 15.46 | 15.42 | 15.42 | 15.42 | 15.42 | 15.42 |
Working Capital | 163.73 | 150.2 | 131.85 | 116.41 | 117.34 | 144.74 |
Book Value Per Share | 12.35 | 13.29 | 12.58 | 9.51 | 10.00 | 11.33 |
Tangible Book Value | 186.86 | 169.12 | 165.59 | 125.48 | 127.35 | 149.76 |
Tangible Book Value Per Share | 12.09 | 10.97 | 10.74 | 8.14 | 8.26 | 9.71 |